Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying

investors.com/news/technology/sanofi-vigil-neuroscience-acquisition

Vigil Neuroscience tripled Thursday after Sanofi agreed to buy it for $470 million plus a CVR tied to its experimental Alzheimer's treatment.
The post Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-05-22 14:06:05.
The Entire Business World on a Single Page. Free to Use →